Macquarie Group LTD Bio Xcel Therapeutics, Inc. Transaction History

Macquarie Group LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$1.14 - $2.97 $1,200 - $3,127	1,053 New	1,053 $1,000
Q3 2022 Nov 14, 2022	SELL	$11.19 - $17.89 $1,913 - $3,059	-171 Reduced 7.26%	2,183 $28,000
Q4 2021 Feb 11, 2022	SELL	$20.12 - $35.09 $16,961 - $29,580	-843 Reduced 26.37%	2,354 $48,000
Q3 2021 Nov 12, 2021	BUY	$23.84 - $32.03 $43,937 - $59,031	1,843 Added 136.12%	3,197 $97,000
Q1 2021 May 14, 2021	BUY	$39.04 - $64.6 $28,343 - $46,899	726 Added 115.61%	1,354 $58,000
Q2 2020 Aug 11, 2020	BUY	$17.62 - $58.71 $11,065 - $36,869	628 New	628 $33,000

3.14M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $12.6M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.